{"id":100178,"date":"2012-01-09T01:46:01","date_gmt":"2012-01-09T01:46:01","guid":{"rendered":"https:\/\/knome.com\/?p=100178"},"modified":"2024-09-12T13:50:09","modified_gmt":"2024-09-12T13:50:09","slug":"knome-expands-scientific-advisory-board","status":"publish","type":"post","link":"https:\/\/www.knome.com\/?p=100178","title":{"rendered":"Knome Expands Scientific Advisory Board"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.27.0&#8243; custom_margin=&#8221;0px||0px||false|false&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_row admin_label=&#8221;row&#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221; theme_builder_area=&#8221;post_content&#8221;][et_pb_heading title=&#8221;Knome Selected as a Genome Interpretation Partner for Illumina Genome Network&#8221; _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; title_text_color=&#8221;#E02B20&#8243; title_font_size=&#8221;25px&#8221; custom_margin=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221;][\/et_pb_heading][et_pb_text admin_label=&#8221;Text&#8221; _builder_version=&#8221;4.27.0&#8243; text_font_size=&#8221;14px&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\" width=\"249\" height=\"250\" alt=\"\" class=\"wp-image-100179 alignnone size-full\" style=\"float: left;\" srcset=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg 249w, https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g-150x150.jpg 150w\" sizes=\"(max-width: 249px) 100vw, 249px\" \/>Drs. David Goldstein and Yaniv Erlich bring genomics expertise as company pursues future growth<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>CAMBRIDGE, MA \u2013 January 9, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv Erlich of the Whitehead Institute for Biomedical Research.<\/p>\n<p>\u201cWe are very pleased to appoint two highly talented genomics experts to our scientific advisory board as we continue to pursue Knome\u2019s mission of improving lives by applying the scientific insights gained from the interpretation of human genomes,\u201d said Martin Tolar, Chief Executive Officer of Knome. \u201cDrs. Goldstein and Erlich each offer incredibly valuable expertise as we pursue new opportunities in drug development and medicine. We look forward to their contributions this year and into the future.\u201d<\/p>\n<p>Dr. David Goldstein is Professor of Molecular Genetics &amp; Microbiology, Professor of Biology and Director of the Center for Human Genome Variation at Duke University. His work focuses on the use of modern genomics to help understand how human genetic variation influences disease. He received his PhD in Biological Sciences from Stanford University and was previously a professor of Genetics at University College London. In 2007, he was also appointed Honorary Professor at the Institute of Neurology at University College London in the UK.<\/p>\n<p>Dr. Goldstein is the author of more than 175 scholarly publications in the areas of population and medical genetics. He is the recipient of one of the first seven nationally awarded Royal Society\/Wolfson research merit awards in the UK for his work in human population genetics. Dr. Goldstein was awarded the Triangle Business Journal Health Care Heroes Award for Innovator\/Researcher in March 2008.<\/p>\n<p>\u201cKnome has been visionary in its early anticipation of the importance of complete human sequence information and is poised to play a key role in helping to advance new ways to interpret genomic data and to assess the implications for diagnostics, drug response, and our understanding of the biology of disease,\u201d said Dr. Goldstein.<\/p>\n<p>Dr. Yaniv Erlich is Andria and Paul Heady Family Fellow and Principal Investigator at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology. He received a bachelor\u2019s degree from Tel-Aviv University at Israel and his PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory. Dr. Erlich\u2019s research interests are computational human genetics. He has extensive experience in developing new algorithms for high throughputs sequencing and to detect disease genes. In two of his studies, he identified the genetic basis of devastating genetic disorders. His lab works on a wide range of topics including developing compressed sensing approach to identify rare genetic variations, devising new algorithms for personal genomics, and using Web 2.0 information for genetic studies.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/3db7acda-6d0c-438a-99be-4c29e7a81ca2-300x150.png\" width=\"300\" height=\"150\" alt=\"\" class=\"wp-image-100182 alignnone size-medium\" style=\"float: right;\" srcset=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/3db7acda-6d0c-438a-99be-4c29e7a81ca2-300x150.png 300w, https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/3db7acda-6d0c-438a-99be-4c29e7a81ca2.png 400w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/>Dr. Erlich is the recipient of the Harold M. Weintraub award, the IEEE\/ACM-CS HPC award, Goldberg-Lindsay Fellowship, Wolf foundation scholarship for Excellence in exact science, and Emmanuel Ax scholarship, and he was selected as one of 2010 Tomorrow\u2019s PIs team of Genome Technology.<\/p>\n<p>\u201cThe potential to apply genomic findings to clinical care represents an enormous opportunity. The challenge will be how best to interpret and deliver that information. I am extremely pleased to join the Knome advisory team to help guide and shape the company\u2019s role in the ongoing discovery of solutions to interpret human genomic information,\u201d said Dr. Erlich.<\/p>\n<p>Knome\u2019s scientific advisory board is currently chaired by Dr. George Church, PhD, Professor of Genetics at Harvard Medical School and Director of the Center for Computational Genetics, and co-founder of Knome. Other members of the board include Lincoln Stein, MD\/PhD, Professor at Cold Spring Harbor Laboratory and Platform Leader of Informatics and Biocomputing at the Ontario Institute for Cancer Research, and Anthony Sinskey, ScD, Professor of Microbiology and Health Sciences and Technology at the Massachusetts Institute of Technology.<\/p>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.0&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;13px&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; theme_builder_area=&#8221;post_content&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<p><strong>About Knome<\/strong><br \/><span>Knome is a commercial stage life sciences company that specializes in the interpretation of human genomes. Knome supports researchers with the informatics and software tools they need to investigate the genetic basis of human disease and drug response. In addition, the company provides researchers, drug developers and clinics with end-to-end genome interpretation solutions.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drs. David Goldstein and Yaniv Erlich bring genomics expertise as company pursues future growth &nbsp; CAMBRIDGE, MA \u2013 January 9, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":100179,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<img class=\"size-full wp-image-100015 alignleft\" src=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/GENALICE.jpg\" alt=\"\" width=\"300\" height=\"70\" \/>\r\n\r\nHARDERWIJK, the Netherlands and CAMBRIDGE, Mass \u2013 January 12, 2015 \u2013 Today GENALICE and Knome, Inc. USA jointly announced a strategic partnership to offer their products together as a turn-key solution for those using next-generation sequencing (NGS) data to interpret patients\u2019 genomes. GENALICE MAP is an ultra-fast and highly accurate preprocessing solution for aligning and calling NGS data and seamlessly connects to Knome\u2019s informatics and genomics interpretation system, the knoSYS<sup>\u00ae<\/sup>\u00a0platform.\r\n\r\nStated CEO and President of Knome, Wolfgang Daum, \u201cThe GENALICE and Knome partnership came about in response to the reality that the amount of NGS data and its increasing usage requires processing and interpreting at an incredible pace. Wide-spread implementation of sequencing in the clinic toward the goal of precision medicine will only make this fact more apparent.\u201d\r\n\r\nWhile both products will continue to be offered separately, customers wanting to take advantage of the combined system can expect a reduction of NGS data bottlenecks, improved ability to annotate and interpret human genomes, and unprecedented control over their data from end-to-end.\r\n\r\nHans Karten, CEO of GENALICE, commented, \u201cWhereas GENALICE MAP speeds up and improves the process of aligning and calling genomes, the knoSYS platform focuses on the annotation and interpretation piece. These two products complement each other beautifully in creating a workflow that eliminates many of the frustrations of wrangling NGS data today.\u201d\r\n\r\n<strong>About Knome, Inc.<\/strong>\r\nKnome, Inc. is a leading provider of human genome interpretation systems and services. Knome provides tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. Designed to accelerate and industrialize the process of interpreting whole genomes, Knome\u2019s big data technologies are helping to smooth the healthcare industry\u2019s transition to molecular-based, precision medicine.\r\n\r\n<strong>About GENALICE<\/strong>\r\nGENALICE is a highly innovative biomedical big data company, with global headquarters in the Netherlands. GENALICE designs and builds groundbreaking software solutions for ultra-fast, highly accurate and cost-effective DNA data processing and analysis on general-purpose hardware. With GENALICE MAP, it introduced the first Next-Generation Sequencing (NGS) data processing pipeline with true population power. By partnering with world-renowned research institutes and healthcare companies, GENALICE is committed to unlocking the potential of whole genome and exome sequencing for biomarker discovery and medical application. More information on GENALICE can be found at\u00a0<a href=\"http:\/\/www.genalice.com\/\" target=\"_blank\" rel=\"noopener\">www.genalice.com<\/a>.\r\n\r\n<strong>Media Contacts<\/strong>\r\n<div>Knome, Inc. USA\r\nJessica Vionas\r\nDirector of Marketing\r\n617-715-1000 x2012\r\njvionas@knome.com<\/div>\r\n<div>GENALICE B.V.\r\nJos Lunenberg\r\nChief Business Officer\r\n+31 88 1221 000\r\njos.lunenberg@genalice.com<\/div>\r\n<p align=\"center\">###<\/p>\r\n<p align=\"center\"><\/p>","_et_gb_content_width":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-100178","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Knome Expands Scientific Advisory Board<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.knome.com\/?p=100178\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Knome Expands Scientific Advisory Board\" \/>\n<meta property=\"og:description\" content=\"Drs. David Goldstein and Yaniv Erlich bring genomics expertise as company pursues future growth &nbsp; CAMBRIDGE, MA \u2013 January 9, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.knome.com\/?p=100178\" \/>\n<meta property=\"og:site_name\" content=\"Knome | Genome Interpretation Systems &amp; Services\" \/>\n<meta property=\"article:published_time\" content=\"2012-01-09T01:46:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T13:50:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"249\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jason Bailey\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jason Bailey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178\"},\"author\":{\"name\":\"Jason Bailey\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"headline\":\"Knome Expands Scientific Advisory Board\",\"datePublished\":\"2012-01-09T01:46:01+00:00\",\"dateModified\":\"2024-09-12T13:50:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178\"},\"wordCount\":903,\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178\",\"url\":\"https:\\\/\\\/www.knome.com\\\/?p=100178\",\"name\":\"Knome Expands Scientific Advisory Board\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\",\"datePublished\":\"2012-01-09T01:46:01+00:00\",\"dateModified\":\"2024-09-12T13:50:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.knome.com\\\/?p=100178\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#primaryimage\",\"url\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\",\"contentUrl\":\"https:\\\/\\\/www.knome.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg\",\"width\":249,\"height\":250},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/?p=100178#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.knome.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Knome Expands Scientific Advisory Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#website\",\"url\":\"https:\\\/\\\/www.knome.com\\\/\",\"name\":\"Knome | Genome Interpretation Systems &amp; Services\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.knome.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.knome.com\\\/#\\\/schema\\\/person\\\/eb7b08ce3aec9801f4fc316c4122bed3\",\"name\":\"Jason Bailey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x\",\"caption\":\"Jason Bailey\"},\"url\":\"https:\\\/\\\/www.knome.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Knome Expands Scientific Advisory Board","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.knome.com\/?p=100178","og_locale":"en_US","og_type":"article","og_title":"Knome Expands Scientific Advisory Board","og_description":"Drs. David Goldstein and Yaniv Erlich bring genomics expertise as company pursues future growth &nbsp; CAMBRIDGE, MA \u2013 January 9, 2012 \u2013 Knome, Inc., the human genome interpretation company, today announced that it has expanded its scientific advisory board to include two respected experts in genomics, Dr. David Goldstein of Duke University and Dr. Yaniv [&hellip;]","og_url":"https:\/\/www.knome.com\/?p=100178","og_site_name":"Knome | Genome Interpretation Systems &amp; Services","article_published_time":"2012-01-09T01:46:01+00:00","article_modified_time":"2024-09-12T13:50:09+00:00","og_image":[{"width":249,"height":250,"url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg","type":"image\/jpeg"}],"author":"Jason Bailey","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jason Bailey","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.knome.com\/?p=100178#article","isPartOf":{"@id":"https:\/\/www.knome.com\/?p=100178"},"author":{"name":"Jason Bailey","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"headline":"Knome Expands Scientific Advisory Board","datePublished":"2012-01-09T01:46:01+00:00","dateModified":"2024-09-12T13:50:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.knome.com\/?p=100178"},"wordCount":903,"image":{"@id":"https:\/\/www.knome.com\/?p=100178#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.knome.com\/?p=100178","url":"https:\/\/www.knome.com\/?p=100178","name":"Knome Expands Scientific Advisory Board","isPartOf":{"@id":"https:\/\/www.knome.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.knome.com\/?p=100178#primaryimage"},"image":{"@id":"https:\/\/www.knome.com\/?p=100178#primaryimage"},"thumbnailUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg","datePublished":"2012-01-09T01:46:01+00:00","dateModified":"2024-09-12T13:50:09+00:00","author":{"@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3"},"breadcrumb":{"@id":"https:\/\/www.knome.com\/?p=100178#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.knome.com\/?p=100178"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.knome.com\/?p=100178#primaryimage","url":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg","contentUrl":"https:\/\/www.knome.com\/wp-content\/uploads\/2024\/09\/DavidYanifFeature-2we287s36y6jxpugt3318g.jpg","width":249,"height":250},{"@type":"BreadcrumbList","@id":"https:\/\/www.knome.com\/?p=100178#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.knome.com\/"},{"@type":"ListItem","position":2,"name":"Knome Expands Scientific Advisory Board"}]},{"@type":"WebSite","@id":"https:\/\/www.knome.com\/#website","url":"https:\/\/www.knome.com\/","name":"Knome | Genome Interpretation Systems &amp; Services","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.knome.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.knome.com\/#\/schema\/person\/eb7b08ce3aec9801f4fc316c4122bed3","name":"Jason Bailey","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","url":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/56bce6b92ef218a6b47a057c253c7c75450a6bb5a6b3e61df84aa47d5443f933?s=96&d=wavatar&r=x","caption":"Jason Bailey"},"url":"https:\/\/www.knome.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=100178"}],"version-history":[{"count":3,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100178\/revisions"}],"predecessor-version":[{"id":100183,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/posts\/100178\/revisions\/100183"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=\/wp\/v2\/media\/100179"}],"wp:attachment":[{"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=100178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=100178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.knome.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=100178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}